1
Background: Individualized pharmacotherapy requires identification of genetic variants predictive of treatment response.
2
Conclusions: Associations of genetic variants with lipid levels over time are complex.
3
Our data also indicate that recombination has resulted in new genetic variants.
4
Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants.
5
Hill and colleagues identified five different genetic variants of the CISH gene.
6
The method represents eQTLs as information flux between genetic variants and transcripts.
7
Systematic classification of HIV-1 genetic variants may be possible by anchored PCR.
8
Whether CRP genetic variants affect lipid metabolism is of importance to investigate.
9
The role of rare genetic variants in CHB has not been elucidated.
10
Certain common genetic variants are also likely to modulate the risk of PD.
11
The many common genetic variants each have a very small individual effect size.
12
Objective: We sought to identify genetic variants associated with IgE levels in Latinos.
13
We present a comprehensive approach to identification of genetic variants to predict TIPN.
14
The crucial point is the way the genetic variants are inherited.
15
Background: Several genomes have now been sequenced, with millions of genetic variants annotated.
16
Acknowledging these genetic variants and their affected pathways may inspire future targeted therapies.
